logo
logo
Sign in

Xerostomia (Dry Mouth) Therapeutics Market Growing Popularity And Emerging Trends In The Market, Forecast To 2025

avatar
David Walker
Xerostomia (Dry Mouth) Therapeutics Market Growing Popularity And Emerging Trends In The Market, Forecast To 2025

The global Xerostomia (Dry Mouth) Therapeutics Market is anticipated to reach USD 796.1 million and is anticipated to grow at a CAGR of 3.2% in the years to come. Xerostomia is a clinical condition of dry mouth and does not show the signs of hyposalivation and symptoms on frequent terms. This condition is observed when the rate of saliva flow is low in comparison with absorption across the oral mucosa coupled with rate of fluid evaporation from the mouth.

Prolonged xerostomia is a significant disease in patients since it affects speech, chewing, denture-wearing, and swallowing activities. The defined causes of hyposalivation and xerostomia are the use of several medications such as antidepressants, anticoagulants, antiretroviral, hypoglycemics, multivitamins and supplements, and anti-inflammatory drugs. Prevalence of xerostomia persists in a large population with different age groups despite following medical or dental consultation.

Download Free Sample Report @ https://www.millioninsights.com/industry-reports/xerostomia-dry-mouth-therapeutics-market/request-sample

Rise in use of prescribed medication coupled with rising prevalence of HIV and cancer are expected to act as primary drivers for market growth. Secondary factors such as easy availability of cost-effective medications along with rise in preference for prescription drugs act as market drivers. In addition, rising cases of depression, Parkinson’s disease, HIV, and hypertension are also expected to contribute significantly to the market development. The market is further triggered by rise in cases of chronic xerostomia due to intake of certain medications. However, significant costs and uneven medical infrastructure are likely to hinder the market growth in the forecast period upto 2025.

Xerostomia (Dry mouth) therapeutics market is segmented into type, product, and region. Type category includes prescription and OTC. “Over-the-counter (OTC)” segment accounts for a larger share and is expected to gain significant momentum in the forecast period owing to wide variety & availability of branded drugs and low-cost products. Product segmentation includes salivary substitutes, salivary stimulants and dentrifices. Dentrifices segment accounted for a significant market share owing to effectiveness, affordability and higher adoption. Geographic segmentation for xerostomia (dry mouth) therapeutics industry includes North America, South America, Europe, Asia-Pacific, Middle East and Africa.

Asia-Pacific’s xerostomia therapeutics market is anticipated to rise at a CAGR of 4.2% in the forthcoming period due to rising awareness, high prevalence of Parkinson’s disease, cancer and HIV. North America followed by Europe accounts for a higher revenue share owing to rising prevalence of xerostomia and other dry mouth diseases such as rheumatoid arthritis, Sjogren’s syndrome and HIV along with rising awareness by government and health care NGOs.

The key players in the xerostomia (dry mouth) therapeutics market include GlaxoSmithKline plc; Church & Dwight Co., Inc.; Colgate-Palmolive Company; Hikma Pharmaceuticals PLC; Pendopharm; Sun Pharmaceuticals Industries Ltd.; Lupin Pharmaceuticals, Inc.; Pfizer, Inc.; Parnell Pharmaceuticals, Inc.; Acacia Pharma; and OraCoat.

Market Segment:

Type Outlook (Market Revenue in USD Million, 2014 - 2025)

  • OTC
  • Prescription

Product Outlook (Market Revenue in USD Million, 2014 - 2025)

  • Salivary Stimulants
  • Salivary Substitutes
  • Dentifrices

Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • South Africa

 

Browse Full Research Report with TOC @ https://www.millioninsights.com/industry-reports/xerostomia-dry-mouth-therapeutics-market

Table of Contents

Chapter 1 Research Methodology & Scope

                 1.1 Information Procurement

                     1.1.1 Purchased database:

                     1.1.2 GVR’s internal database

                 1.2 Research Methodology

                 1.3 Geographic Scope & Assumptions

                 1.4 Region-wise market calculation

                     1.4.1 Region-wise market: Base estimates

                     1.4.2 Global market: CAGR calculation

                 1.5 Region-based Segment Share Calculation

                 1.6 List of Secondary Sources

Chapter 2 Executive Summary

                 2.1 Market Snapshot

Chapter 3 Xerostomia Therapeutics Market Variables, Trends & Scope

                 3.1 Market Segmentation& Scope

                     3.1.1 Market Driver Analysis

                         3.1.1.1 Growing geriatric population base

                         3.1.1.2 Growing prevalence of diseases such as Sjogren’s Syndrome, HIV, diabetes, Alzheimer’s disease, and others.

                         3.1.1.3 Increasing adoption of chemotherapy and radiotherapy in cancer treatment

                         3.1.1.4 Increasing use of prescription medicines

                         3.1.1.5 Easy availability and cost effectiveness of medicines

                     3.1.2 Market restraint analysis

                         3.1.2.1 Lack of awareness of xerostomia in developing and underdeveloped economies.

                         3.1.2.2 Nonavailability of effective treatment.

                 3.2 Penetration & GrowthPprospect Mapping

                 3.3 Xerostomia Therapeutics- SWOT Analysis, By Factor (political & legal, economic and technological)

                 3.4 Industry Analysis - Porter’s                                               

Continued…

Get in Touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: [email protected]

Global Headquarters

Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: 1-408-610-2300

Email: [email protected]

Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184

collect
0
avatar
David Walker
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more